Molecular structure of Anisindione, CAS Number: 117-37-3
Anisindione (CAS 117-37-3)
Application:
Anisindione is a synthetic anticoagulant
CAS Number:
117-37-3
Molecular Weight:
252.26
Molecular Formula:
C16H12O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Anisindione acts as an inhibitor of protein synthesis. It accomplishes this by attaching to the amino acid histidine, consequently inhibiting the formation of proteins from particular genes. Additionally, it exhibits the capability to permeate water, a property linked to its potential to convey compounds that are insoluble in water across cellular membranes.
Anisindione (CAS 117-37-3) References
- Coumarin derivatives and breast-feeding. | Clark, SL., et al. 2000. Obstet Gynecol. 95: 938-40. PMID: 10831996
- Anticoagulation with anisindione in a patient with a warfarin-induced skin eruption. | Spyropoulos, AC., et al. 2003. Pharmacotherapy. 23: 533-6. PMID: 12680483
- Anisindione: a new anticoagulant with unusual properties. | LANGE, K., et al. 1958. Am Heart J. 55: 73-9. PMID: 13520554
- Clinical experience experience with the anticoagulant anisindione (miradon). | PAUL, HA., et al. 1959. Surg Gynecol Obstet. 108: 605-15. PMID: 13647217
- Evaluation of anticoagulant therapy with anisindione (miradon). | CONNELL, WF. and MAYER, GA. 1959. Can Med Assoc J. 80: 785-90. PMID: 13652026
- [Preliminary clinical investigations on a new indandione type anticoagulant: anisindione]. | BALLERINI, G. and LA PAGLIA, S. 1959. Prog Med (Napoli). 15: 46-8. PMID: 13658270
- [Clinical evaluation of the anticoagulant, anisindione]. | BUZZI, A. and CARBAJAL, B. 1961. Prensa Med Argent. 48: 1826-9. PMID: 13875273
- An evaluation of anisindione, a new and useful oral anticoagulant. Preliminary report. | WILLIS, PW. and ZWEIFLER, AJ. 1962. J Mich State Med Soc. 61: 1386-7. PMID: 14000965
- Cubane Electrochemistry: Direct Conversion of Cubane Carboxylic Acids to Alkoxy Cubanes Using the Hofer-Moest Reaction under Flow Conditions. | Collin, DE., et al. 2020. Chemistry. 26: 374-378. PMID: 31593312
- Individuating Possibly Repurposable Drugs and Drug Targets for COVID-19 Treatment Through Hypothesis-Driven Systems Medicine Using CoVex. | Matschinske, J., et al. 2020. Assay Drug Dev Technol. 18: 348-355. PMID: 33164550
- Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies. | Guo, Z., et al. 2021. Clin Cardiol. 44: 917-924. PMID: 34013988
- Clinically significant drug interactions with the oral anticoagulants. | Freedman, MD. and Olatidoye, AG. 1994. Drug Saf. 10: 381-94. PMID: 8037888
- Anticoagulation with anisindione in patients who are intolerant of warfarin. | Grosset, AB., et al. 1994. Am J Hematol. 46: 138-40. PMID: 8172181
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Anisindione, 1 g | sc-291902 | 1 g | $80.00 | |||
Anisindione, 5 g | sc-291902A | 5 g | $220.00 |